Evaluate SLN360 in Participants With Elevated Lipoprotein(a) at High Risk of Atherosclerotic Cardiovascular Disease Events
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05537571 |
Recruitment Status :
Active, not recruiting
First Posted : September 13, 2022
Last Update Posted : February 13, 2024
|
Sponsor:
Silence Therapeutics plc
Information provided by (Responsible Party):
Silence Therapeutics plc
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Active, not recruiting |
---|---|
Actual Primary Completion Date : | January 11, 2024 |
Estimated Study Completion Date : | June 2024 |